NDC 52544-892

Jolivette

Norethindrone

Jolivette is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Norethindrone.

Product ID52544-892_a2d1ea06-7dc9-11e8-8537-ee90676ff592
NDC52544-892
Product TypeHuman Prescription Drug
Proprietary NameJolivette
Generic NameNorethindrone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2003-03-01
Marketing End Date2020-12-31
Marketing CategoryNDA / NDA
Application NumberNDA016954
Labeler NameActavis Pharma, Inc.
Substance NameNORETHINDRONE
Active Ingredient Strength0 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN

Packaging

NDC 52544-892-28

6 BLISTER PACK in 1 BOX (52544-892-28) > 28 TABLET in 1 BLISTER PACK
Marketing Start Date2003-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52544-892-28 [52544089228]

Jolivette TABLET
Marketing CategoryNDA
Application NumberNDA016954
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-03-01
Marketing End Date2020-12-31

Drug Details

Active Ingredients

IngredientStrength
NORETHINDRONE.35 mg/1

OpenFDA Data

SPL SET ID:b4bcfbe3-8050-4bb6-b3e0-068ddfb60c93
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 757594
  • 198042
  • 748961
  • Pharmacological Class

    • Progesterone Congeners [CS]
    • Progestin [EPC]
    • Progesterone Congeners [CS]
    • Progestin [EPC]

    Medicade Reported Pricing

    52544089228 JOLIVETTE TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Jolivette" or generic name "Norethindrone"

    NDCBrand NameGeneric Name
    52544-892JolivetteNORETHINDRONE
    51862-102CamilaNorethindrone
    51862-884CAMILANORETHINDRONE
    16714-440DEBLITANENorethindrone
    0555-0344ErrinNorethindrone
    51862-100ErrinNorethindrone
    51862-886ERRINNORETHINDRONE
    57297-877Jencyclanorethindrone
    50102-300LyleqNORETHINDRONE
    53002-1793LyleqNORETHINDRONE
    50102-100LYZAnorethindrone
    53002-1687LYZAnorethindrone
    52544-629Nora BENorethindrone
    0378-7272NorethindroneNorethindrone
    0378-7292NORETHINDRONEnorethindrone
    50090-2150NorethindroneNorethindrone
    50090-6161NORETHINDRONENORETHINDRONE
    57297-876NORETHINDRONENORETHINDRONE
    63187-748NorethindroneNorethindrone
    42291-650Norethindrone AcetateNorethindrone
    50268-602Norethindrone AcetateNorethindrone
    50090-3235Norlydanorethindrone
    51660-127NORLYROCnorethindrone
    50458-194Ortho MicronorNORETHINDRONE
    16714-441SHAROBELNorethindrone
    50102-200TulanaNORETHINDRONE
    53002-2687TulanaNORETHINDRONE

    Trademark Results [Jolivette]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    JOLIVETTE
    JOLIVETTE
    76522008 2907097 Live/Registered
    ACTAVIS HOLDCO US, INC.
    2003-06-03

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.